The pathology of familial breast cancer. How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?

被引:17
作者
Bertwistle D. [1 ]
Ashworth A. [1 ]
机构
[1] The Breakthrough Toby Robins, Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road
关键词
BRCA1; BRCA2; Breast cancer; Cell cycle checkpoints; DNA repair; Gene expression;
D O I
10.1186/bcr12
中图分类号
学科分类号
摘要
Women with mutations in the breast cancer susceptibility genes, BRCA1 and BRCA2, have an increased risk of developing breast cancer. Both BRCA1 and BRCA2 are thought to be tumour suppressor genes since the wild type alleles of these genes are lost in tumours from heterozygous carriers. Several functions have been proposed for the proteins encoded by these genes which could explain their roles in tumour suppression. Both BRCA1 and BRCA2 have been suggested to have a role in transcriptional regulation and several potential BRCA1 target genes have been identified. The nature of these genes suggests that loss of BRCA1 could lead to inappropriate proliferation, consistent with the high mitotic grade of BRCA1-associated tumours. BRCA1 and BRCA2 have also been implicated in DNA repair and regulation of centrosome number. Loss of either of these functions would be expected to lead to chromosomal instability, which is observed in BRCA1 and BRCA2-associated tumours. Taken together, these studies give an insight into the pathogenesis of BRCA-associated tumours and will inform future therapeutic strategies.
引用
收藏
页码:41 / 47
相关论文
共 65 条
[1]  
Rahman, N., Stratton, M.R., The genetics of breast cancer susceptibility (1998) Annu Rev Genet, 32, pp. 95-121
[2]  
Bertwistle, D., Ashworth, A., Functions of the BRCA1 and BRCA2 genes (1998) Curr Opin Genet Dev, 8, pp. 14-20
[3]  
Easton, D., Breast cancer genes: What are the real risks? (1997) Nature Genet, 16, pp. 210-211
[4]  
Miki, Y., Swensen, J., Shattuck-Eidens, D., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 (1994) Science, 266, pp. 66-71
[5]  
Wooster, R., Bignell, G., Lancaster, J., Identification of the breast cancer susceptibility gene BRCA2 (1995) Nature, 378, pp. 789-791
[6]  
Bork, P., Blomberg, N., Nilges, M., Internal repeats in the BRCA2 protein sequence (1996) Nature Genet, 13, pp. 22-23
[7]  
Bignell, G., Micklem, G., Stratton, M.R., Ashworth, A., Wooster, R., The BRC repeats are conserved in mammalian BRCA2 proteins (1997) Hum Mol Genet, 6, pp. 53-58
[8]  
Chen, P.L., Chen, C.F., Chen, Y., The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment (1998) Proc Natl Acad Sci USA, 95, pp. 5287-5292
[9]  
Wong, A.K.C., Pero, R., Ormonde, P.A., Tavtigian, S.V., Bartel, P.L., RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRC (1997) J Biol Chem, 272, pp. 31941-31944
[10]  
Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases (1997) Lancet, 349, pp. 1505-1510. , Breast Cancer Linkage Consortium